Oestrogen-mediated regulation of somatostatin receptor expression in human breast cancer cell lines assessed with 99mTc-depreotide

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 31, Issue 7, 2004, Pages 1022-1030

  Van Den Bossche, B ^a   D'Haeninck, E ^a   De Vos, F ^a   Dierckx, R A ^a   Van Belle, S ^a   Bracke, M ^a   Van De Wiele, C ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

99mTc depreotide; Binding assay; Human breast cancer cell line; Oestrogen regulation; Somatostatin receptor expression

Indexed keywords

DEPREOTIDE TC 99M; ESTROGEN; ESTROGEN RECEPTOR; FULVESTRANT; MESSENGER RNA; OCTREOTIDE; PENTETIC ACID; SOMATOSTATIN RECEPTOR; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; FEMALE; HORMONAL REGULATION; HUMAN; HUMAN CELL; NEUROMODULATION; PROTEIN EXPRESSION; RECEPTOR AFFINITY; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; RISK ASSESSMENT; SCATCHARD PLOT; SCINTIGRAPHY; WESTERN BLOTTING;

EID: 3142685152     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-004-1500-6     Document Type: Article

References (32)

1. Raynor K, Reisine T. Somatostatin receptors. Crit Rev Neurobiol 1992; 16:273-289.
2. Reichlin S. Somatostatin. N Eng J Med 1983; 309:1495-1563.
3. Patel YC. Somatostatin and its receptor family. Front Neuroendocrinol 1999; 20:157-198.
4. Lamberts SWJ, Krenning EP, Reubi JC. The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr Rev 1991; 12:450-482.
5. Seytono-Han B, Schenkelmans MS, Foekens JA, Klijn JGM. Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells. Cancer Res 1987; 47:1566-1570.
6. Scambia G, Panici PB, Baiocchi G, Perrone L, Iacobelli S, Mancusco S. Antiproliferative effects of somatostatin and the somatostatin analogue SMS 201-995 on three human breast cancer cell lines. J Cancer Res Clin Oncol 1988; 114:306-308.
7. Reisine T, Bell G. Molecular biology of somatostatin receptors. Endocr Rev 1995; 16:427-442.
8. Panetta R, Patel YC. Expression of mRNA for all five human somatostatin receptors (hSSTR1-5) in pituitary tumors. Life Sci 1995; 56:333-342.
9. Reubi JC, Kappeler A, Waser B, Laissue JA, Hipkin RW, Schonbrunn A. Immunohistochemical localization of somatostatin receptors SS2A in human tumors. Am J Pathol 1998; 153:233-245.
10. Bruno JF, Xu Y, Song J, Berelowitz M. Molecular cloning and functional expression of a brain-specific somatostatin receptor. Proc Natl Acad Sci U S A 1992; 89:11151-11155.
11. Hoyer D, Bell GI, Berlowitz M, et al. Classification and nomenclature of somatostatin receptors. Trends Pharmacol Sci 1995; 16:86-88.
12. Reubi JC, Krenning E, Lamberts SWJ, Kvols L. In vitro detection of somatostatin receptors in human tumors. Metabolism 1992; 41 (9 Suppl 2):104-110.
13. Vikic-Topic S, Raisch KP, Kvols LK, Vuk-Pavlovic S. Expression of somatostatin receptor subtypes in breast carcinoma, carcinoid tumor, and renal cell carcinoma. J Clin Endocrinol Metab 1995; 80:2974-2979.
14. Bootsma AH, van Eijck C, Schouten KK, et al. Somatostatin receptor-positive primary breast tumors: genetic, patient and tumor characteristics. Int J Cancer 1993; 54:357-362.
15. Reubi JC, Waser B, Foekens J, et al. Somatostatin receptor incidence and distribution in breast cancer using receptor autoradiography: relationship to EGF receptors. Int J Cancer 1990; 46:416-420.
16. van Eijck CHJ, Krenning EP, Bootsma A, et al. Somatostatinreceptor scintigraphy in primary breast cancer. Lancet 1994; 343:640-643.
17. Reubi JC, Waser B, Schaer JC, Laissue JA. Somatostatin receptor SS1-SS5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands. Eur J Nucl Med 2001; 38:836-846.
18. Schulz S, Helmholz T, Schmitt J, Franke K, Otto HJ, Weise W. True positive somatostatin receptor scintigraphy in primary breast cancer correlates with expression of sst2A and sst5. Breast Cancer Res Treat 2002; 72:221-226.
19. Reubi JC, Torhorst J. Relationship between somatostatin, EGF-and steroid-hormone receptors in breast cancer. Cancer 1989; 64:1254-1260.
20. Xu Y, Song J, Berelowitz M, Bruno JF. Oestrogen regulates somatostatin receptor subtype 2 messenger ribonucleic acid expression in human breast cancer cells. Endocrinology 1996; 137:5634-5640.
21. 99mTc-P829. Cancer Res 1998; 58:1850-1859.
22. 99m P829: characterization of a technetium-99-labeled somatostatin receptor-binding peptide. In: Nicolini M, Mazzi U, eds. Technetium, rhenium and other metals in chemistry and nuclear medicine. Padua: SGE; 1999:473-478.
23. 99m-labeled somatostatin receptor-binding peptides. J Nucl Med 1996; 37:1016-1022.
24. Berthois Y, Katzenellebogen JA, Katzenellebogen BS. Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc Natl Acad Sci U S A 1986; 83:2496-2500.
25. Helboe L, Møller M, Norregaard L, Schiødt M, Stidsen CE. Development of selective antibodies against the human somatostatin receptor subtypes SS1-SS5. Mol Brain Res 1997; 49:82-88.
26. Kimura N, Tomizawa S, Arai KN, Kimura N. Chronic treatment with oestrogen up-regulates expression of SS2 messenger ribonucleic acid (mRNA) but down-regulates expression of SS5 mRNA in rat pituitaries. Endocrinology 1998; 139:1573-1580.
27. Djordjijevic D, Zhang J, Priam M, et al. Effect of 17beta-estradiol on somatostatin receptor expression and inhibitory effect on growth hormone and prolactin release in rat pituitary cell cultures. Endocrinology 1998; 139:2272-2277.
28. 1 cells. Endocrinology 1995; 136:5070-5075.
29. Visser-Wisselaar HA, Van Uffelen CJC, Van Koetsveld PM, et al. 17 Estradiol dependent regulation of somatostatin receptor subtype expression in the 7315 b prolactin secreting rat pituitary tumor in vitro and in vivo. Endocrinology 1997; 138:1180-1189.
30. Xu Y, Berelowitz M, Bruno JF. Characterization of the promoter region of the human somatostatin receptor subtype 2 gene and localization of sequences required for estrogen-responsiveness. Mol Cell Endocrinol 1998; 139:71-77.
31. Masters JR, Thomson JA, Daly-Burns B, et al. Short tandem repeat profiling provides an international reference standard for human cell lines. Proc Natl Acad Sci U S A 2001; 98:8012-8017.
32. Schaer JC, Waser B, Mengod G, Reubi JC. Somatostatin receptor subtypes SS1, SS2, SS3 and SS5 expression in human pituitary, gastroentero-pancreatic and mammary tumors: comparison of mRNA analysis with receptor autoradiography. Int J Cancer 1997; 70:530-537.